Cite
HARVARD Citation
Rizzoli, R. et al. (2016). Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study. Osteoporosis international. 27 (6), pp. 2099-2107. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rizzoli, R. et al. (2016). Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study. Osteoporosis international. 27 (6), pp. 2099-2107. [Online].